• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

Model Number ICF100
Device Problems Leak/Splash (1354); Deformation Due to Compressive Stress (2889); Insufficient Information (3190)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/02/2018
Event Type  malfunction  
Manufacturer Narrative
Eccentric balloons may be identified during the prepping procedure. Users are advised per dfu to inflate the balloon with 30 to 40 ml (maximum) of sterile saline to verify proper inflation and balloon shape. Per specification, some degree of eccentricity is acceptable. As long as the balloon is occlusive, eccentricity should not affect the performance of the device. However if it is not occlusive, occlusion of the aorta will not be able to be initiated and a simple device exchange at the beginning of the procedure may be required or it may necessitate a change in operative strategy. A change in operative strategy typically occurs due to unanticipated anatomical or procedural factors and is not related to the device. There may be scenarios where a change in operative strategy is due to a malfunction of the device, in these cases, the potential for injury is not remote. In this case, a cross-clamp was used to arrest the heart. The device was not returned for evaluation at this time. The root cause of the event remains indeterminable. If new information becomes available or the device is returned for evaluation, a supplemental report will be submitted. The device history record (dhr) was not able to be reviewed as the device lot number was not provided. Edwards will continue to review and monitor all events. Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
Event Description
It was reported that an intra-aortic occlusion catheter was used in an excision of a left atrial myxoma and complete occlusion of the aorta was not achieved. A cross-clamp was used and case went well. No patient injury was noted. As reported, the aortic diameter by pre-operative echo measured was 2. 45 cm. The team deflated the balloon several times and repositioned the catheter but this did not result in occlusion. Several hundred milliliters of cardioplegia were given and the color flow doppler revealed leaking around the balloon. At one point, there was 35 cc injected into the balloon with a balloon pressure of 535 mmhg. Cross-clamp was done and the heart was arrested as expected. Upon finishing the case, the balloon was inspected. A volume of 35 cc was injected into the balloon and no leakage was noted. However, on close inspection of the balloon, it was noted to be oddly malformed.
Manufacturer Narrative
Device was returned with visible traces of blood and was examined in the biohazard area of the lab. As received, intraclude balloon was inflated and appeared to be abnormal in shape after inflation (see figures 2 & 3). All other through lumens were found to be patent without any leakage or occlusion. No other visual damage or other abnormalities were found. Engineering task has been opened and assigned for further investigation. See attached evaluation photos. Customer report of abnormal balloon shape was confirmed through product evaluation. Per the engineering evaluation, a manufacturing defect was not confirmed and the root cause cannot be determined at this time. As reported, the catheter shaft was inflated and deflated several times. It is unknown how the device was inspected, tested, and/or handled. It is possible that the issue occurred as a result of use.
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Manufacturer (Section D)
one edwards way
irvine CA 92614
MDR Report Key7820137
MDR Text Key118746321
Report Number3008500478-2018-00080
Device Sequence Number1
Product Code DXC
Combination Product (y/n)N
PMA/PMN Number
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup
Report Date 08/02/2018
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received08/27/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Device Model NumberICF100
Device Catalogue NumberICF100
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No